Genetic Predispositions and Metabolic Readiness for GLP-1 Therapy Individual response to GLP-1 therapy varies significantly based on genetic variants in appetite regulation and glucose metabolism pathways
Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates
A state-licensed, board-certified MD, DO, or qualified medical provider reviews your intake and creates a treatment plan personalized for you
Pancreatic -cell electrical activity and insulin secretion: of mice and men
Safety and Monitoring Checklist For either route, track objective data: Fasting glucose and/or A1c IGF-1 labs Blood pressure Fluid retention/edema Joint discomfort or carpal tunnel-like symptoms Sleep quality and recovery markers If stacking GH-axis compounds, increase lab frequency and lower starting doses
Substances on the Negative List are strictly regulated Any formulation containing ingredients listed in the DRGD Negative List falls outside the scope of compliant food supplements and may instead be classified as a health supplement or drug product